牛皮关节炎管理:对PANLAR,EULAR和GRAPPA治疗建议进行比较分析
Wilson Bautista-Molano1, Daniel G Fernández-Ávila2,3, Enrique Roberto Soriano4
1Rheumatology Section, University Hospital Fundación Santa Fe de Bogotá, School of Medicine Universidad El Bosque, Carrera 7 Bis No. 124-56, Bogotá 110111, Colombia.
Therapeutic advances in musculoskeletal disease
|March 5, 2026
概括
来自EULAR,GRAPPA和PANLAR的牛皮关节炎治疗指南共享核心原则,但在治疗顺序和重点上有所不同. 国际合作是全球协调牛皮关节炎护理的关键.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮关节炎 (PsA) 是一种复杂的炎症状况,影响关节,皮肤和其他区域.
- 像EULAR,GRAPPA和PANLAR这样的跨国组织提供了PsA治疗指南.
- 这些指导方针的变化可能源于区域差异和不断变化的科学证据.
研究的目的:
- 为了比较来自EULAR,GRAPPA和PANLAR的牛皮关节炎 (PsA) 的治疗建议.
- 确定全球PSA治疗标准化中的相似之处,差异和挑战.
主要方法:
- 对EULAR,GRAPPA和PANLAR指导方针进行比较文献综述.
- 对药物和非药物PSA管理策略的系统评估.
- 对治疗顺序,向疗法和领域重点差异的分析.
主要成果:
- 所有指导方针都倡导多学科,个性化的PsA治疗.
- 在治疗顺序,使用向合成DMARDs以及管理肌肉骨外表现方面存在差异.
- PANLAR强调区域访问,EULAR纳入真实世界的数据,GRAPPA专注于基于域的处理.
结论:
- 欧拉,GRAPPA和PANLAR指南共享PsA的基本治疗原则,但存在关键差异.
- 这些差异影响了 psoriatic 关节炎管理中的临床决策.
- 加强国际合作可以协调PsA治疗建议,以改善全球患者的治疗结果.
相关概念视频
01:11Genome-wide Association Studies-GWAS
16.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.2K
01:21Rheumatic Heart Disease III: Medical Management
434
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
434
01:26Peptic Ulcer Disease IV: Management
592
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
592
01:29Inflammatory Bowel Disease IV: Pharmacological Management
873
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
873
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
670
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
670
01:17Pericarditis III: Medical Management
446
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
446